S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
US Dollar Replaced By "Biden Bucks"? (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
US Dollar Replaced By "Biden Bucks"? (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
US Dollar Replaced By "Biden Bucks"? (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
US Dollar Replaced By "Biden Bucks"? (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
Germans urged to cap heat in offices this winter to save gas
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
Germany urged to cap heat in offices this winter to save gas
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
LON:OBD

Oxford BioDynamics - OBD Share Forecast, Price & News

GBX 13.25
-0.50 (-3.64%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
13
14.10
50-Day Range
12.32
18.29
52-Week Range
11.25
54
Volume
83,343 shs
Average Volume
288,665 shs
Market Capitalization
£13.30 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
OBD stock logo

About Oxford BioDynamics (LON:OBD) Stock

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Analyst Upgrades and Downgrades

Separately, Shore Capital reiterated a "house stock" rating on shares of Oxford BioDynamics in a research report on Tuesday, June 28th.

Oxford BioDynamics Price Performance

LON:OBD opened at GBX 13.25 ($0.16) on Friday. The business's fifty day moving average is GBX 14.63 and its 200 day moving average is GBX 19.35. Oxford BioDynamics has a fifty-two week low of GBX 11.25 ($0.14) and a fifty-two week high of GBX 54 ($0.65). The company has a market capitalization of £13.30 million and a PE ratio of -1.84. The company has a debt-to-equity ratio of 99.34, a quick ratio of 2.80 and a current ratio of 2.98.

Insider Activity

In other Oxford BioDynamics news, insider Matthew Wakefield acquired 25,000 shares of the stock in a transaction dated Friday, May 20th. The shares were acquired at an average cost of GBX 17 ($0.21) per share, for a total transaction of £4,250 ($5,135.33).

Receive OBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter.

OBD Stock News Headlines

Oxford BioDynamics Plc (OBD.L)
Oxford Biodyn Share News (OBD)
Oxford BioDynamics PLC
Oxford Biodyn Regulatory News
Oxford BioDynamics losses widen in first half
See More Headlines
Receive OBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter.

OBD Company Calendar

Last Earnings
6/16/2020
Today
8/14/2022

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
39
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£176,000.00
Cash Flow
GBX 4.13 per share
Book Value
GBX 6.50 per share

Miscellaneous

Free Float
N/A
Market Cap
£13.30 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Jon Anthony Joseph Burrows B.Sc. (Age 59)
    M.Sc., Ph.D., CEO & Director
    Comp: $463k
  • Mr. Paul Leslie Stockdale F.C.A. (Age 47)
    M.A., CFO & Director
    Comp: $202k
  • Dr. Alexandre Akoulitchev Ma (Oxon) (Age 60)
    Ph.D., Chief Scientific Officer & Director
    Comp: $236k
  • Mr. Thomas G. Guiel B.A.
    Chief Operating Officer
  • Dr. Jayne Green B.Sc.
    Ph.D., Director of Operations
  • Dr. Aroul Ramadass M.Sc.
    Ph.D., Ph.D.(CANTAB), PDF (OXON), FCPS, FRA, Chief Technology Officer
  • Dr. Ewan Hunter B.Sc.
    Ph.D., BSC, Ph.D., (KCL), Group CDO
  • Mr. Bipin Patel
    Head of RA/QA
  • T. Demain
    Company Sec.
  • Dr. Steven Tucker M.D.
    FACP, Group Clinical Director













OBD Stock - Frequently Asked Questions

How have OBD shares performed in 2022?

Oxford BioDynamics' stock was trading at GBX 38.25 at the beginning of the year. Since then, OBD shares have decreased by 65.4% and is now trading at GBX 13.25.
View the best growth stocks for 2022 here
.

How were Oxford BioDynamics' earnings last quarter?

Oxford BioDynamics Plc (LON:OBD) released its earnings results on Tuesday, June, 16th. The biotechnology company reported ($2.20) earnings per share for the quarter.

What other stocks do shareholders of Oxford BioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford BioDynamics investors own include Oxford Biomedica (OXB), Frontline (FRO), Fate Therapeutics (FATE), Cargojet (CJT), China Unicom (Hong Kong) (CHU), Casey's General Stores (CASY), Buckle (BKE), Biffa (BIFF), AXT (AXTI) and Grupo Aval Acciones y Valores (AVAL).

What is Oxford BioDynamics' stock symbol?

Oxford BioDynamics trades on the London Stock Exchange (LON) under the ticker symbol "OBD."

How do I buy shares of Oxford BioDynamics?

Shares of OBD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Oxford BioDynamics' stock price today?

One share of OBD stock can currently be purchased for approximately GBX 13.25.

How much money does Oxford BioDynamics make?

Oxford BioDynamics (LON:OBD) has a market capitalization of £13.30 million and generates £176,000.00 in revenue each year.

How can I contact Oxford BioDynamics?

Oxford BioDynamics' mailing address is 26 Beaumont Street, OXFORD, OX1 2NP, United Kingdom. The official website for the company is www.oxfordbiodynamics.com. The biotechnology company can be reached via phone at +44-1865-518910.

This page (LON:OBD) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.